These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24422938)

  • 41. [Characteristics of university students using stimulants for cognitive enhancement: a pilot study].
    Franke AG; Schwarze CE; Christmann M; Bonertz C; Hildt E; Lieb K
    Psychiatr Prax; 2012 May; 39(4):174-80. PubMed ID: 22318482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Attention deficit hyperactivity disorder in prison.
    Ghanizadeh A; Akhondzadeh S
    J Am Acad Psychiatry Law; 2009; 37(2):278. PubMed ID: 19535565
    [No Abstract]   [Full Text] [Related]  

  • 43. Sociological approaches to the study of drug use and drug policy.
    Stevens A
    Int J Drug Policy; 2011 Nov; 22(6):399-403. PubMed ID: 22078055
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
    Kollins SH
    J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The consumable vice: caffeine, public health, and the law.
    Hodge JG; Scanlon M; Corbe A; Sorensen A
    J Contemp Health Law Policy; 2010; 27(1):76-119. PubMed ID: 21322400
    [No Abstract]   [Full Text] [Related]  

  • 46. [Methylphenidate of retard forms in children and adolescents with ADHD - an overview].
    Pelz R; Banaschewski T; Becker K
    Klin Padiatr; 2008; 220(2):93-100. PubMed ID: 18157763
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of d-amphetamine and related central nervous system stimulants in children.
    Pediatrics; 1973 Feb; 51(2):302-5. PubMed ID: 4695865
    [No Abstract]   [Full Text] [Related]  

  • 48. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Caffeine, cannabis and cocaine: from automedication to 'automutilation' in adults with ADHD].
    Pereira RR; van de Wetering BJ
    Ned Tijdschr Geneeskd; 2004 Dec; 148(52):2573-6. PubMed ID: 15646857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. From attention-deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non-medical stimulant use: connecting the dots.
    Poulin C
    Addiction; 2007 May; 102(5):740-51. PubMed ID: 17506151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How the harm reduction movement contrasts itself against punitive prohibition.
    Tammi T; Hurme T
    Int J Drug Policy; 2007 Mar; 18(2):84-7. PubMed ID: 17689349
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlled extended-release methylphenidate formulation in humans.
    Parasrampuria DA; Schoedel KA; Schuller R; Gu J; Ciccone P; Silber SA; Sellers EM
    J Clin Pharmacol; 2007 Dec; 47(12):1476-88. PubMed ID: 17962423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study.
    Konstenius M; Jayaram-Lindström N; Beck O; Franck J
    Drug Alcohol Depend; 2010 Apr; 108(1-2):130-3. PubMed ID: 20015599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2.
    Riddle EL; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2007 Sep; 571(1):25-8. PubMed ID: 17618619
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does extended medication with amphetamine or methylphenidate reduce growth in hyperactive children?
    Sund AM; Zeiner P
    Nord J Psychiatry; 2002; 56(1):53-7. PubMed ID: 11869467
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The chemical detection of doping among athletes].
    Machata G
    Dtsch Z Gesamte Gerichtl Med; 1966; 57(1):335-41. PubMed ID: 4383662
    [No Abstract]   [Full Text] [Related]  

  • 57. Reconsideration of contemporary U.S. drug policy.
    Solano PL
    J Ment Health Policy Econ; 2002 Dec; 5(4):175-83. PubMed ID: 14578551
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.
    Kollins SH
    J Atten Disord; 2008 Sep; 12(2):115-25. PubMed ID: 18192623
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cannabis control policy: No rational basis yet for legalization.
    Kalant H
    Clin Pharmacol Ther; 2015 Jun; 97(6):538-40. PubMed ID: 25778495
    [No Abstract]   [Full Text] [Related]  

  • 60. Legalization of medical marijuana (Cannabis).
    Porche DJ
    Am J Mens Health; 2013 Nov; 7(6):449. PubMed ID: 24027206
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.